Is rifabutin prophylaxis against Mycobacterium avium complex infection in HIV infection worthwhile? | Sexually Transmitted Infections

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

See original article:

Is rifabutin prophylaxis against Mycobacterium avium complex infection in HIV infection worthwhile? The net impact on patients suggests not. - August 01, 1996

Correction

Is rifabutin prophylaxis against Mycobacterium avium complex infection in HIV infection worthwhile?

Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Is rifabutin prophylaxis against Mycobacterium avium complex infection in HIV infection worthwhile?

Sexually Transmitted Infections 1996;72:388.